Orecchia S - Search Results

1

FLIP overexpression inhibits death receptor-induced apoptosis in malignant mesothelial cells.

Rippo MR, Moretti S, Vescovi S, Tomasetti M, Orecchia S, Amici G, Catalano A, Procopio A. Rippo MR, et al. Among authors: orecchia s. Oncogene. 2004 Oct 14;23(47):7753-60. doi: 10.1038/sj.onc.1208051. Oncogene. 2004. PMID: 15334061

2

Enhanced antitumor therapy by inhibition of p21waf1 in human malignant mesothelioma.

Lazzarini R, Moretti S, Orecchia S, Betta PG, Procopio A, Catalano A. Lazzarini R, et al. Among authors: orecchia s. Clin Cancer Res. 2008 Aug 15;14(16):5099-107. doi: 10.1158/1078-0432.CCR-08-0255. Clin Cancer Res. 2008. PMID: 18698027

3

Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma.

Strizzi L, Catalano A, Vianale G, Orecchia S, Casalini A, Tassi G, Puntoni R, Mutti L, Procopio A. Strizzi L, et al. Among authors: orecchia s. J Pathol. 2001 Apr;193(4):468-75. doi: 10.1002/path.824. J Pathol. 2001. PMID: 11276005

4

Characterization of human malignant mesothelioma cell lines orthotopically implanted in the pleural cavity of immunodeficient mice for their ability to grow and form metastasis.

Martarelli D, Catalano A, Procopio A, Orecchia S, Libener R, Santoni G. Martarelli D, et al. Among authors: orecchia s. BMC Cancer. 2006 May 17;6:130. doi: 10.1186/1471-2407-6-130. BMC Cancer. 2006. PMID: 16704740 Free PMC article.

5

The brain specific Ras exchange factor CDC25 Mm: modulation of its activity through Gi-protein-mediated signals.

Zippel R, Orecchia S, Sturani E, Martegani E. Zippel R, et al. Among authors: orecchia s. Oncogene. 1996 Jun 20;12(12):2697-703. Oncogene. 1996. PMID: 8700529

6

Point mutations in the tyrosine kinase domain release the oncogenic and metastatic potential of the Ron receptor.

Santoro MM, Penengo L, Minetto M, Orecchia S, Cilli M, Gaudino G. Santoro MM, et al. Among authors: orecchia s. Oncogene. 1998 Aug 13;17(6):741-9. doi: 10.1038/sj.onc.1201994. Oncogene. 1998. PMID: 9715276

7

The Ron oncogenic activity induced by the MEN2B-like substitution overcomes the requirement for the multifunctional docking site.

Santoro MM, Penengo L, Orecchia S, Cilli M, Gaudino G. Santoro MM, et al. Among authors: orecchia s. Oncogene. 2000 Oct 26;19(45):5208-11. doi: 10.1038/sj.onc.1203819. Oncogene. 2000. PMID: 11064459

8

The present role of immunohistochemistry in the diagnosis of malignant mesothelioma.

Betta P, Orecchia S, Schillaci F, Salvio M, Libener R. Betta P, et al. Among authors: orecchia s. Pathologica. 2003 Oct;95(5):299-300. Pathologica. 2003. PMID: 14989035 No abstract available.

9

Aberrant E-cadherin and gamma-catenin expression in malignant mesothelioma and its diagnostic and biological relevance.

Orecchia S, Schillaci F, Salvio M, Libener R, Betta PG. Orecchia S, et al. Lung Cancer. 2004 Aug;45 Suppl 1:S37-43. doi: 10.1016/j.lungcan.2004.04.027. Lung Cancer. 2004. PMID: 15261432

10

Asbestos induces doxorubicin resistance in MM98 mesothelioma cells via HIF-1alpha.

Riganti C, Doublier S, Aldieri E, Orecchia S, Betta PG, Gazzano E, Ghigo D, Bosia A. Riganti C, et al. Among authors: orecchia s. Eur Respir J. 2008 Aug;32(2):443-51. doi: 10.1183/09031936.00090407. Epub 2008 Apr 2. Eur Respir J. 2008. PMID: 18385176 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters